Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Infinity Discovery, Inc.”

12 pharma patents match "Infinity Discovery, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "Infinity Discovery, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “Infinity Discovery, Inc.” · 30,257 patents in full index Clear search

  1. US 8609706

    Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

    Infinity Discovery, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  2. US 8431566

    Cyclopamine lactam analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  3. US 8426436

    Heterocyclic cyclopamine analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  4. US 8357676

    Ansamycin formulations and methods of use thereof

    Infinity Discovery, Inc. · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  5. US 8304428

    Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

    Infinity Discovery, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  6. US 8293760

    Cyclopamine lactam analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  7. US 7994191

    Heterocyclic cyclopamine analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  8. US 7964590

    Cyclopamine lactam analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  9. US 7928244

    Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

    Infinity Discovery, Inc. · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  10. US 7875628

    Cyclopamine analogues and methods of use thereof

    Infinity Discovery, Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  11. US 7648994

    Heterocyclic cyclopamine analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Jan 19, 2010 · Expires Jan 14, 2030

    granted

  12. US 7230004

    Cyclopamine analogues and methods of use thereof

    Infinity Discovery, Inc. · Granted Jun 12, 2007 · Expires Jun 7, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.